Strength
150 mg/5mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323097210
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
8/21/2024
Active Ingredients
FOSAPREPITANT DIMEGLUMINEApproval Type
Generic (ANDA)
FDA Application
ANDA206197On Market Since
9/5/2019
Pharmacological Classes
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Cytochrome P450 3A4 Inhibitors
Neurokinin 1 Antagonists
Substance P/Neurokinin-1 Receptor Antagonist
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
TOPIRAMATE 25 MG TABLET
Generic
00904692861•Major Pharmaceuticals
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011505•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011510•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011516•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
47335070713•Sun Pharmaceutical Industries Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
47335070786•Sun Pharmaceutical Industries Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
65862017160•Aurobindo Pharma Limited
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68084034201•American Health Packaging
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68382013805•Zydus Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68382013814•Zydus Pharmaceuticals (USA) Inc.
$0.0257
per EA